What is the primary goal of regulatory professionals in negotiations with the FDA about product labeling?

The primary goal of regulatory professionals during negotiations with the FDA about product labeling is to advocate for the company's interests. This involves working to achieve a balance between compliance with FDA regulations and ensuring that the product can be marketed effectively. By advocating for the company's interests, regulatory professionals aim to secure labeling that accurately reflects the product's benefits and uses while still adhering to safety and efficacy requirements set forth by the FDA. This role includes understanding the regulatory landscape and the potential impact of specific language on how the product is perceived in the market.

While compliance with regulations and ensuring consumer safety are critical aspects of product labeling, the primary focus during these negotiations is to favorably position the product in the marketplace. Thus, the efforts made during discussions with the FDA revolve around how the labeling can be structured to support the company's objectives while still maintaining necessary safety standards.